Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Conduit Pharmaceuticals ( (CDT) ) has shared an announcement.
On May 5, 2025, Conduit Pharmaceuticals Inc. held a special meeting of stockholders where a quorum was achieved with proxies representing over one-third of the company’s common stock. During the meeting, stockholders approved amendments to the company’s Certificate of Incorporation to allow for reverse stock splits at ratios determined by the board of directors. This decision could potentially impact the company’s stock structure and market perception.
More about Conduit Pharmaceuticals
Average Trading Volume: 5,766,367
Technical Sentiment Signal: Sell
Current Market Cap: $6.09M
Learn more about CDT stock on TipRanks’ Stock Analysis page.